Showing results (101-110 of 172) with videos related to

Sort By:
Pageof 18
International Journal of Rheumatic Diseases|August 18, 2012
Comparison of expectations of physicians and patients with rheumatoid arthritis for rheumatology clinic visits: a pilot, multicenter, international studyHongyan Wen, H Ralph Schumacher, Xiaofeng Li, et al.
Annals of Translational Medicine|April 21, 2020
Prevalence of bone mineral density loss and potential risk factors for osteopenia and osteoporosis in rheumatic patients in China: logistic regression and random forest analysisXi Zhang, Zonglin Dai, Eric H Y Lau, et al.
Rheumatology and Immunology Research|July 24, 2023
Consensus on targeted drug therapy for spondyloarthritisXinping Tian, Mengtao Li, Shengyun Liu, et al.
International Journal of Rheumatic Diseases|January 21, 2025
The Association of Persistent Hyperuricemia With Liver Function and the Management of Uric Acid Levels: Insights From a Three-Year Prospective Cohort StudyYina Wang, Minli Qiu, Liuzhong Zhou, et al.
Journal of Ethnopharmacology|October 11, 2021
Efficacy and safety of Fengshi Gutong Capsule in patients with active ankylosing spondylitis: A 4-week randomized controlled, double-blinded, double-dummy trialYa Xie, Liudan Tu, Yanli Zhang, et al.
Clinics (Sao Paulo, Brazil)|November 26, 2015
Serum from patients with ankylosing spondylitis can increase PPARD, fra-1, MMP7, OPG and RANKL expression in MG63 cellsZaiying Hu, Dongfang Lin, Jun Qi, et al.
International Journal of Rheumatic Diseases|June 10, 2014
Evaluation of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis in Chinese patients with chronic back pain: results of a 2-year follow-up studyZhiming Lin, Zetao Liao, Jianlin Huang, et al.
Arthritis Care & Research|July 6, 2020
Effects of Vitamin D Supplementation on Disabling Foot Pain in Patients With Symptomatic Knee OsteoarthritisLiudan Tu, Shuang Zheng, Flavia Cicuttini, et al.
Clinical and Experimental Rheumatology|October 17, 2025
Efficacy and safety of monoclonal antibody AK111 in the treatment of active ankylosing spondylitis: a randomised, double-blind, placebo-controlled, multicentre phase II clinical studyHua Ye, Shengyun Liu, Yongjun Mei, et al.
Annals of the Rheumatic Diseases|March 12, 2013
Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trialFeng Huang, Jieruo Gu, Ping Zhu, et al.
Pageof 18